Please see the high level functionalities of this HCV patient registry monitoring HCV infection, cofactors, free-interferon treatments (DAA), HCC screening, drug resistance, all laboratory tests and procedures (imaging, elastography, biopsy). Data can be exported, analysed with automated dashboards. Interfaces with LIS and HIS is available. Contact us for a Live Demo. More to come.

1. HEPATIC®
VERSION 1.6
A dedicated tool for HCV-
infected patient care &
treatment
(C) ABL 2016 -- PROPRIETARY INFORMATION – PERSONAL AND LIMITED USE ONLY

2. ABL OFFERING OVERVIEW
Software for clinics (EMR, registry, data mining)
•HIV, HCV,
•HBV, HPV, TB
Software for laboratories (Sanger and NGS data analysis)
•HIV, HCV, HBV, CMV, TB , HSV
IT services (interface, integration, consolidation)
•Private labs, NHLS, GeneXpert MTB
•Billing systems for private insurances
Reagents for sequencing (Sanger and NGS,
•HIV, HCV
•TB, HBV, HPV
(C) ABL 2016 -- PROPRIETARY INFORMATION – PERSONAL AND LIMITED USE ONLY

3. HEPATIC®
WHY ?
 New direct antiviral agents (DAAs)
 Interferon-free based Rx
 Promise of HCV cure
 Numerous clinical trials
 New Rx strategies will happen
 Large estimates of HCV-infected pts
 Few are diagnosed
 More is needed
 Patient status
 HCV testing
 Post-treatment and HCV cure assessment
 Progression or not to HCC and transplantation
 Are they specific risk factors?
 Several DAA treatment courses over the years
What ?
 Web-based platform
 Collaborative, multi-user, multi-site
 HCV-infected patients
 Data collection and analysis
 Routine & research
 Developed by ABL together
with the AEEH (Asociacion
Espanola para el Estudio del
Higado) (Spain)
 launched for research in November
2013
 http://aeeh.es/2011/10/hepatic/
(C) ABL 2016 -- PROPRIETARY INFORMATION – PERSONAL AND LIMITED USE ONLY

4. HEPATIC® STRUCTURE (V1.6)
Any HCV + Patient
Demographics
Identification,
Gender, Residence
Geno/Subtype, IL28,
Death
Naïve, Pre-treated
Rx history
Cofactors
Liver
Non-liver
Visits
Standard
Vitals, Labs,
Procedures
Treatment
Type/Dosing, AEs
Outcome
HCC screening
Non invasive testing
Biopsy
Diagnosis
Treatment
(C) ABL 2016 -- PROPRIETARY INFORMATION – PERSONAL AND LIMITED USE ONLY

5. HEPATIC® VERSION 1.6 Main & New features
(C) ABL 2016 -- PROPRIETARY INFORMATION – PERSONAL AND LIMITED USE ONLY

6. DEMOGRAPHICS
(C) ABL 2016 -- PROPRIETARY INFORMATION – PERSONAL AND LIMITED USE ONLY

7. PRE-TREATMENTS HISTORY
(C) ABL 2016 -- PROPRIETARY INFORMATION – PERSONAL AND LIMITED USE ONLY

8. TREATMENTS
(C) ABL 2016 -- PROPRIETARY INFORMATION – PERSONAL AND LIMITED USE ONLY

9. HCC SCREENING
(C) ABL 2016 -- PROPRIETARY INFORMATION – PERSONAL AND LIMITED USE ONLY

10. MANAGEMENT OF THE SITE
Call with local
dial-in
Training
(Webcast)
Data hosting
Support
Remote
access
 Other technologies can be used
to manage the site
 Skype, Hangouts, Viber, WhatsApp
 VPN
 also regular phone 
 Team is speaking:
 English, French, German, Portuguese
and Spanish
 Support request is solved
usually in less than 2 business
days
(C) ABL 2016 -- PROPRIETARY INFORMATION – PERSONAL AND LIMITED USE ONLY

11. THANK YOU!
Ronan Boulmé
ronan@ablsa.com
Matthieu Barralon
matthieu@ablsa.com
(C) ABL 2016 -- PROPRIETARY INFORMATION – PERSONAL AND LIMITED USE ONLY